Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Ri Kim

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
BMJ Open|June 15, 2014
Acupuncture as analgesia for non-emergent acute non-specific neck pain, ankle sprain and primary headache in an emergency department setting: a protocol for a parallel group, randomised, controlled pilot trialKun Hyung Kim, Ji Ho Ryu, Maeng Real Park, et al.
International Journal of Nanomedicine|January 8, 2015
Evaluation of silica nanoparticle toxicity after topical exposure for 90 daysHwa Jung Ryu, Nak-won Seong, Byoung Joon So, et al.
Cancer Letters|July 9, 2018
Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitinationYong Sun Lee, Yu Yeon Jung, Mi Hee Park, et al.
Redox Biology|June 10, 2022
The antioxidant enzyme Peroxiredoxin-1 controls stroke-associated microglia against acute ischemic strokeSinai Kim, Wonhyo Lee, Huiju Jo, et al.
International Journal of Nanomedicine|January 8, 2015
A 90-day study of sub-chronic oral toxicity of 20 nm positively charged zinc oxide nanoparticles in Sprague Dawley ratsHark-Soo Park, Seon-Ju Kim, Taek-Jin Lee, et al.
Cancer Research and Treatment|December 30, 2014
Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter AnalysisJunshik Hong, Seok Jin Kim, Jae-Sook Ahn, et al.
International Journal of Nanomedicine|January 8, 2015
A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley ratsHark-Soo Park, Sung-Sup Shin, Eun Ho Meang, et al.
Cancer Research and Treatment|March 30, 2023
Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) StudyYu Ri Kim, Jin Seok Kim, Won Seog Kim, et al.
Chonnam Medical Journal|June 4, 2026
Clinical Outcomes and Use of Implantable Cardioverter-Defibrillator in Ischemic Heart Failure Patients with Reduced Ejection Fraction: A Retrospective Observational StudyKyung Hoon Cho, Ki Hong Lee, Yong-Kyu Lee, et al.
International Journal of Nanomedicine|January 8, 2015
Toxicity of colloidal silica nanoparticles administered orally for 90 days in ratsYu-Ri Kim, Seung-Young Lee, Eun Jeong Lee, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
BMJ Open|June 15, 2014
Acupuncture as analgesia for non-emergent acute non-specific neck pain, ankle sprain and primary headache in an emergency department setting: a protocol for a parallel group, randomised, controlled pilot trialKun Hyung Kim, Ji Ho Ryu, Maeng Real Park, et al.
International Journal of Nanomedicine|January 8, 2015
Evaluation of silica nanoparticle toxicity after topical exposure for 90 daysHwa Jung Ryu, Nak-won Seong, Byoung Joon So, et al.
Cancer Letters|July 9, 2018
Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitinationYong Sun Lee, Yu Yeon Jung, Mi Hee Park, et al.
Redox Biology|June 10, 2022
The antioxidant enzyme Peroxiredoxin-1 controls stroke-associated microglia against acute ischemic strokeSinai Kim, Wonhyo Lee, Huiju Jo, et al.
International Journal of Nanomedicine|January 8, 2015
A 90-day study of sub-chronic oral toxicity of 20 nm positively charged zinc oxide nanoparticles in Sprague Dawley ratsHark-Soo Park, Seon-Ju Kim, Taek-Jin Lee, et al.
Cancer Research and Treatment|December 30, 2014
Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter AnalysisJunshik Hong, Seok Jin Kim, Jae-Sook Ahn, et al.
International Journal of Nanomedicine|January 8, 2015
A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley ratsHark-Soo Park, Sung-Sup Shin, Eun Ho Meang, et al.
Cancer Research and Treatment|March 30, 2023
Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) StudyYu Ri Kim, Jin Seok Kim, Won Seog Kim, et al.
Chonnam Medical Journal|June 4, 2026
Clinical Outcomes and Use of Implantable Cardioverter-Defibrillator in Ischemic Heart Failure Patients with Reduced Ejection Fraction: A Retrospective Observational StudyKyung Hoon Cho, Ki Hong Lee, Yong-Kyu Lee, et al.
International Journal of Nanomedicine|January 8, 2015
Toxicity of colloidal silica nanoparticles administered orally for 90 days in ratsYu-Ri Kim, Seung-Young Lee, Eun Jeong Lee, et al.
Pageof 20